It was revealed on Wednesday that Time Warner (NYSE:
TWX
), which owns the cable networks TNT and TBS among others, has
reported 1Q earnings that, regarding gains in TV advertising,
beat analysts' expectations.
It was a good quarter for both the company and for the people
producing ads, who will no doubt be celebrating with
Mad Men
-esque parties (although that show is an AMC production).
Earnings basically rose 67 cents per share, while analysts had
projects 64 cents. Sales also exceeded analyst predictions.
TWX gets over 70% of its income from TV, something that has
been helped of late by hit TV shows like
The Big Band Theory
. With people sat down to watch the adventures of Sheldon and
wallow in nerd-related humor, the advertisers are able to have a
field day. As a result, advertising at the networks went up 6%.
In addition, subscription fees for TWX networks rose 5%.
In total, sales went up 4.4% to $6.98 billion from $6.68
billion this time last year. The analyst estimate sat at $6.82
billion, so the company beat estimates here too.
It doesn't end there. Time Warner's filmed-entertainment
revenue went up a full 6.9% to $2.78 billion. That number was
helped, rather bizarrely, by ticket sales for the February film
Journey 2: The Mysterious Island
. With the Harry Potter franchise / cash cow now at an end, TWX
is desperately looking for something to fill the void. So far
this year, Journey 2 has proved to be the unlikely hero, pulling
in $101,911,345 so far.
OK, so the budget was $79 million but, when you add foreign
ticket sales of $221 million, the fill is a hit. Who would have
thought that The Rock would really, genuinely come to the rescue
in real life?
On the minus side, TWX's publishing business, which puts out
People
,
Sports Illustrated
and
Time
magazines, went down 3.1%. Net income also declined 11% to $583
million, or 59 cents per share, from $653 million, or 59 cents
per share, the previous year.
Still, Time Warner went up 1.2% overall to $37.92 on
Tuesday.
Follow me
@BCallwood
.
(c) 2012 Benzinga.com. All rights reserved. This material
may not be published in its entirety or redistributed without
the approval of Benzinga.